Please use this identifier to cite or link to this item:
https://doi.org/10.1038/sj.bjp.0701995
Title: | Anti-nociceptive responses produced by human putative counterpart of nocistatin | Authors: | Minami, T. Okuda-Ashitaka, E. Nishiuchi, Y. Kimura, T. Tachibana, S. Mori, H. Ito, S. |
Keywords: | Allodynia Hyperalgesia Nociceptin/orphanin FQ Prostaglandin E2 Spinal cord |
Issue Date: | 1998 | Citation: | Minami, T., Okuda-Ashitaka, E., Nishiuchi, Y., Kimura, T., Tachibana, S., Mori, H., Ito, S. (1998). Anti-nociceptive responses produced by human putative counterpart of nocistatin. British Journal of Pharmacology 124 (6) : 1016-1018. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.bjp.0701995 | Abstract: | b-nocistatin is a heptadecapeptide produced from bovine prepronociceptin and blocks the induction of hyperalgesia and touch-evoked pain (allodynia) by intrathecal administration of nociceptin or prostaglandin E2 (PGE2). Human prepronociceptin may generate a 30-amino acid peptide different in length from b-nocistatin. Here, we examine whether the human putative counterpart of nocistatin (h-nocistatin) possessed the same biological activities as b-nocistatin. Simultaneous intrathecal injection of h-nocistatin in mice blocked the induction of allodynia by nociceptin and PGE2 in a dose-dependent manner with ID50 values of 329 pg kg-1 and 16.6 ng kg-1, respectively. h-nocistatin was about 10 times less potent than b-nocistatin. h-nocistatin also attenuated the nociceptin- and PGE2-induced hyperalgesia. These results demonstrate that h-nocistatin is biologically active and may be involved in the processing of pain at the spinal level in humans. | Source Title: | British Journal of Pharmacology | URI: | http://scholarbank.nus.edu.sg/handle/10635/100100 | ISSN: | 00071188 | DOI: | 10.1038/sj.bjp.0701995 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.